Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China flag China · Delayed Price · Currency is CNY
10.26
+0.23 (2.29%)
Feb 4, 2026, 1:15 PM CST

SHE:300016 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
352.29257.46748.45766.73895.021,014
Trading Asset Securities
343.64350.77----
Cash & Short-Term Investments
695.93608.23748.45766.73895.021,014
Cash Growth
-0.38%-18.73%-2.38%-14.33%-11.71%308.10%
Accounts Receivable
222.6176.36188.55112.67142.52190.37
Other Receivables
1.29.545.878.395.8115.36
Receivables
223.81185.9194.42121.06148.33205.73
Inventory
367.75362.09244.86276.22250.01117.12
Other Current Assets
51.6414.959.071412.7214.48
Total Current Assets
1,3391,1711,1971,1781,3061,351
Property, Plant & Equipment
1,059976.03876.23840.46795.3739.48
Long-Term Investments
528.45536.76556.06561.19553.2508.43
Goodwill
46.9246.92-31.8251.2351.23
Other Intangible Assets
152.07160.82128.39125.1138.99138.04
Long-Term Accounts Receivable
1.471.43----
Long-Term Deferred Tax Assets
36.7341.3341.3839.3218.1511.07
Long-Term Deferred Charges
21.8824.9417.236.9532.436.17
Other Long-Term Assets
3618.113.385.838.9212.1
Total Assets
3,2222,9782,8192,8192,9042,848
Accounts Payable
192.12171.32115.12140.9141.13137.03
Accrued Expenses
13.1344.534.8932.0526.0624.12
Short-Term Debt
195.31140.02175.56107.6179.08143.91
Current Portion of Long-Term Debt
140.24912.410.0920.136
Current Portion of Leases
-3.263.042.740.27-
Current Income Taxes Payable
17.56---0.010.01
Current Unearned Revenue
6.018.762.014.453.87.95
Other Current Liabilities
38.738.3816.144.8315.0924.54
Total Current Liabilities
603.04455.23359.17302.67285.56343.54
Long-Term Debt
154600.24592.55516.28476.1553.18
Long-Term Leases
1.974.87.179.980.14-
Long-Term Unearned Revenue
26.1516.8411.747.8910.4513.76
Long-Term Deferred Tax Liabilities
67.6370.9362.4858.5645.9845.01
Total Liabilities
852.81,1481,033895.39818.22955.5
Common Stock
562.87491.95491.93491.96492.72494.49
Additional Paid-In Capital
697.91135.34135.22135.3201.27188.53
Retained Earnings
946.03926.45912.791,0191,042945.96
Treasury Stock
----0.1-9.06-18.01
Comprehensive Income & Other
4.25113.86110.67130.27130.04130.93
Total Common Equity
2,2111,6681,6511,7761,8571,742
Minority Interest
157.92161.9135.69146.88229.03150.17
Shareholders' Equity
2,3691,8291,7861,9232,0861,892
Total Liabilities & Equity
3,2222,9782,8192,8192,9042,848
Total Debt
491.48797.32790.72646.71575.72703.09
Net Cash (Debt)
204.45-189.09-42.28120.03319.31310.64
Net Cash Growth
----62.41%2.79%25.05%
Net Cash Per Share
0.44-0.42-0.090.210.660.64
Filing Date Shares Outstanding
562.87491.95491.93491.96492.72494.49
Total Common Shares Outstanding
562.87491.95491.93491.96492.72494.49
Working Capital
736.08715.95837.62875.341,0211,008
Book Value Per Share
3.933.393.363.613.773.52
Tangible Book Value
2,0121,4601,5221,6191,6671,553
Tangible Book Value Per Share
3.572.973.093.293.383.14
Buildings
-700.49561.7557.21532.04503.45
Machinery
-567.37503.01470.31400.02288.48
Construction In Progress
-70.26110.3944.994987.3
Source: S&P Global Market Intelligence. Standard template. Financial Sources.